Uploaded on Mar 11, 2024
According to the latest research report by IMARC Group, The global healthcare interoperability solutions market size reached US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.0 Billion by 2032, exhibiting a growth rate (CAGR) of 12.24% during 2024-2032. More Info:- https://www.imarcgroup.com/healthcare-interoperability-solutions-market
Healthcare Interoperability Solutions Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
Global Healthcare
Interoperability Solutions
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
In ternat ional Market Analys is Research and Consul t ing Group is a leading adv iser on management
s t rategy and market research wor ldwide. We par tner wi th c l ients in a l l regions and indust ry
vert ica ls to ident i fy thei r h ighest -value oppor tuni t ies, address thei r most cr i t ica l chal lenges, and
t ransform thei r bus inesses.
IMARC’s in format ion products inc lude major market , sc ient i f ic , economic and technological
developments for bus iness leaders in pharmaceut ica l , indust r ia l , and h igh technology
organizat ions. Market forecasts and indust ry analys is for b iotechnology, advanced mater ia ls ,
chemicals , food and beverage, t ravel and tour ism, nanotechnology and novel process ing methods
are at the top of the company’s exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight in to the dynamics o f companies and
markets wi th c lose cooperat ion at a l l levels of the c l ient organizat ion. This ensures that our c l ients
achieve unmatchable compet i t ive advantage, bui ld more pro f ic ient organizat ions, and secure
las t ing resul ts .
A c c o r d i n g t o t h e l a t e s t r e p o r t b y I M A R C G r o u p , t i t l e d " H e a l t h c a r e I n t e r o p e r a b i l i t y S o l u t i o n s
M a r k e t : G l o b a l I n d u s t r y T r e n d s , S h a r e , S i z e , G r o w t h , O p p o r t u n i t y a n d F o r e c a s t 2 0 2 4 -
2 0 3 2 , " t h e g l o b a l h e a l t h c a r e i n t e r o p e r a b i l i t y s o l u t i o n s m a r k e t s i z e r e a c h e d U S $ 3 . 9 B i l l i o n i n
2 0 2 3 .
F a c t o r s A f f e c t i n g t h e Gr o wt h o f th e He a l t h ca re I n t e ro p er ab i l i t y So l u t i o n s In d u s t ry :
Report Go ve r n me n t R eg u la t i o n s a n d I n i t i a t i v e s :
G o v e r n m e n t s a r e r e c o g n i z i n g t h e i m p o r t a n c e o f h e a l t h c a r e s o l u t i o n s i n d e l i v e r i n g e f f i c i e n t ,
c o s t - e f f e c t i v e , a n d h i g h - q u a l i t y h e a l t h c a r e s e r v i c e s . A s a r e s u l t , t h e y a r e i m p l e m e n t i n g
Highlight and s e v e r a l r e g u l a t i o n s a n d i n i t i a t i v e s a i m e d a t p r o m o t i n g t h e a d o p t i o n o f s u c h t e c h n o l o g i e s ,
p a r t i c u l a r l y f o c u s i n g o n e n s u r i n g s e c u r e d a t a s h a r i n g a n d i n t e r o p e r a b i l i t y . T h e s e r e g u l a t i o n s
o f t e n i n c l u d e m a n d a t e s t h a t h e a l t h c a r e p r o v i d e r s a d o p t c e r t a i n i n t e r o p e r a b i l i t y s t a n d a r d s ,
Description w h i c h a r e c r u c i a l f o r e n a b l i n g d i f f e r e n t I T s y s t e m s a n d s o f t w a r e a p p l i c a t i o n s t o c o m m u n i c a t e ,
e x c h a n g e d a t a , a n d u t i l i z e t h a t i n f o r m a t i o n e f f e c t i v e l y .
M o r e o v e r , t h e a i m i s t o e n h a n c e h e a l t h c a r e d e l i v e r y b y m a k i n g p a t i e n t i n f o r m a t i o n e a s i l y
a v a i l a b l e t o h e a l t h c a r e p r o f e s s i o n a l s , t h e r e b y i m p r o v i n g c l i n i c a l d e c i s i o n - m a k i n g , p a t i e n t
o u t c o m e s , a n d o v e r a l l h e a l t h c a r e e f f i c i e n c y . F u r t h e r m o r e , s u c h r e g u l a t o r y e n v i r o n m e n t s
s u p p o r t i n n o v a t i o n w h i l e e n s u r i n g t h e p r i v a c y a n d s e c u r i t y o f p a t i e n t d a t a , t h e r e b y f o s t e r i n g
t r u s t i n t h e u s e o f t e c h n o l o g y i n h e a l t h c a r e .
Growing Need for Improved Pat ient Care:
The i nc r e as in g em phas i s o n de l i ve r i n g h igh - qu a l i t y pa t i e n t ca r e i s esca l a t i ng t he
dem and f o r i n t e r ope r ab i l i t y i n hea l t hca r e . I n a dd i t i on , co o r d ina t ed ca r e r e l i es on t he
sea m less exch ange o f hea l t h i n f o r m a t ion ac r o ss va r i ou s hea l t hca r e p r ov ide r s wh ich
ens ur es t ha t pa t i en t s r e ce i ve e f f i c i en t , t i m e ly , and e f f ec t i v e t r e a t m en t . A l so , t he
i n t e r ope r ab i l i t y so lu t i ons f ac i l i t a t e t h i s by e nab l i n g qu i ck and se cu r e a cces s t o
Report pa t i en t da t a , r ega r d les s o f whe r e t he ca r e i s de l i ve r ed , t hu s i n f l uenc ing t he m ar k e t
g r ow t h .
Highlight and I t a l so he l ps hea l t hca r e p r o f ess iona l s m a ke w e l l - i n f o r m e d de c i s ion s , l e ad ing t o im p r oved d iag nos t i c accu r acy , m or e e f f ec t i ve t r ea t m en t p lans , a nd u l t im a t e l y ,
enha nced pa t i e n t ou t com es . M or e ove r , i n t e r ope r a b i l i t y supp o r t s t he co n t i nu i t y o f
Description ca r e , a s pa t i en t s m ove a c r os s d i f f e r en t h ea l t h ca r e se t t i ngs , e nsu r in g t h a t ev e r y
hea l t hca r e p r o v ide r t he y enc oun t e r ha s com p le t e and acc u r a t e i n f o r m a t ion .
Heal thcare Advancements:
The va r io us adva ncem en t s i n h ea l t hca r e t ha t sup po r t t he im p lem en t a t i on o f
i n t e r ope r ab i l i t y s o lu t i on s a r e i n f l uen c ing t he m ar ke t g r ow t h . Add i t i ona l l y , e lec t r o n i c
hea l t h r eco r ds ( EHRs) a r e p r ov id ing a d i g i t a l ve r s ion o f pa t i en t s ' p ape r ch a r t s t ha t
can be sh a r ed ac r oss d i f f e r e n t h ea l t h ca r e se t t i ngs , t hus i n f l uenc ing t he m ar k e t
g r ow t h .
EHRs a re a l so des igned to be accessed by a l l pe rsonne l invo lved in a
pa t ien t ' s ca re , i nc lud ing c l i n ic ians , lab techn ic ians , and pharmac is ts , ensur ing
tha t the in fo rmat ion is comp le te , accura te , and upda ted . A long w i th th i s ,
hea l th i n fo rmat ion exchange sys tems a l l ow fo r the secure sha r ing o f hea l th
da ta ac ross d i f f e ren t hea l thcare o rgan iza t ions , enhanc ing co l labora t ive ca re .
Bes ides th is , c loud-based so lu t ions a re ga in ing t rac t ion , o f fe r ing sca lab le ,
Report f l ex ib le , and cos t -e f fec t i ve op t ions fo r s to r ing and shar ing la rge vo lumes o f hea l th da ta .
Highlight and Request for a PDF sample o f th is repor t :
h t tps : / /www. imarcgroup .com/hea l thcare - in te roperab i l i t y -so lu t ions-marke t / reque
Description s tsamp le
Report Description
Global Heal thcare Interoperabi l i ty Solut ions Market Trends:
At p r es en t , t he g r o w ing a dop t io n o f i n t e r op e r ab i l i t y s t and a r ds su ch a s hea l t h l e ve l seve n ( HL7 ) and f a s t hea l t hca r e
i n t e r ope r a b i l i t y r esou r c es ( F HI R) f a c i l i t a t e t he e xchan ge o f h ea l t hc a r e da t a be t ween d is pa r a t e sys t e m s an d im pr ov e
i n t e r ope r a b i l i t y . M o r eov e r , t he i n t eg r a t i on o f b loc kcha in f o r enhan c ing da t a sec u r i t y , i n t eg r i t y , a nd i n t e r op e r ab i l i t y i n
hea l t h ca r e by p r ov id in g a de cen t r a l i zed an d t am per - p r oo f p l a t f o r m f o r s t o r i ng a nd sha r ing pa t ie n t r ec o r ds an d o t he r
sens i t i ve d a t a .
Bes ide s t h i s , app l i ca t i on p r o g r am m ing i n t e r f ac es ( AP I s ) and m ic r ose r v i ces a r ch i t ec t u r e a r e be in g em p loye d t o d eve lo p
m od u la r and sc a lab le i n t e r ope r ab i l i t y s o lu t i o ns t ha t ena b le seam less i n t eg r a t i on and com m u n ica t i on be t we en va r i ous
hea l t h ca r e a pp l i ca t i ons an d s ys t em s . Fu r t he r m or e , a sh i f t t owa r d pa t i e n t - c en t r i c i n t e r op e r ab i l i t y so lu t i ons t ha t p r i o r i t i z e
t he se am le ss exc hang e o f pa t i en t da t a ac r o ss d i f f e r en t he a l t hca r e p r ov ide r s , im p r o v ing ca r e c oo r d in a t i on , pa t i en t
enga gem en t , a nd o ve r a l l hea l t hca r e ou t com es a r e i n f l uenc i ng t h e m ar ke t g r o w t h .
Look i ng f o rw ard , t he mark e t t o reach US$ 11 . 0 B i l l i on by 2032 , ex h i b i t i ng a g r ow t h ra t e ( CA G R) o f 12 . 24 % d ur i n g
2024 - 203 2 .
V i ew Repo r t T O C, F i g ures and T ab l e s : h t t ps : / / w w w . i mar cgrou p . com / he a l t h care - i n t e r oper ab i l i t y - s o l u t i ons - mar ke t
Breakup by Type:
• Software Solut ions
o EHR Interoperabi l i ty Solut ions
o Lab System Interoperabi l i ty
Solut ions
o Imaging System Interoperabi l i ty
Solut ions
Report o Healthcare Information Exchange
Interoperabi l i ty Solutions
Segmentation o Enterprise Interoperabi l i ty Solut ions
o Others
• Services
Breakup by Level:
• Foundational
• Structural
• Semantic
Breakup by Deployment:
• Cloud-based
• On-premises
Report Breakup by End Use:
Segmentation • Healthcare Providers
o Hospitals and Cl inics
o Long-Term Care Centers
o Diagnost ic and Imaging Centers
o Others
• Healthcare Payers
• Pharmacies
Breakup by Region:
• North America
• Europe
• Asia-Pacifi c
• Latin America
• Middle East and Afr ica
Report
Segmentation
• Deevita LLC
• Epic Systems Corporation
• Infor (Koch Industries Inc.)
Competitive • International Business Machines Corporation
• InterSystems Corporation
Landscape • Koninkli jke Phi l ips N.V.
with Key • NextGen Healthcare Inc.
• Oracle Corporation
Players
• Orion Health group of companies
• OSP Labs
• Veradigm LLC
How has the global healthcare interoperability
solutions market performed so far, and how will it
perform in the coming years?
What are the drivers, restraints, and opportunities in
the global healthcare interoperability solutions market?
What is the impact of each driver, restraint, and
Key opportunity on the global healthcare interoperability solutions market?
Questions What are the key regional markets?
Answered in
Which countries represent the most attractive
the Report healthcare interoperability solutions market?
What is the breakup of the market based on the type?
Which is the most attractive type in the healthcare
interoperability solutions market?
What is the breakup of the market based on the level?
Which is the most attractive level in the healthcare
interoperability solutions market?
What is the breakup of the market based on the
deployment?
Which is the most attractive deployment in the
Key healthcare interoperability solutions market?
Questions What is the breakup of the market based on the end use?
Answered in Which is the most attractive end use in the healthcare
interoperability solutions market?
the Report
What is the competitive structure of the market?
Who are the key players/companies in the global
healthcare interoperability solutions market?
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a ke h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
Table of 2 . 4 M a r k e t E s t i m a t i o n2 . 4 . 1 B o t t o m - U p A p p r o a c h
2 . 4 . 2 To p - D o w n A p p r o a c h
2 . 5 Fo r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
Contents 4 G l o b a l H e a l t h c a r e I n t e r o p e r a b i l i t y S o l u t i o n s M a r ke t - I n t r o d u c t i o n4 . 1 O v e r v i e w
4 . 2 M a r k e t D y n a m i c s
4 . 3 I n d u s t r y Tr e n d s
4 . 4 C o m p e t i t i v e I n t e l l i g e n c e
5 G l o b a l H e a l t h c a r e I n t e r o p e r a b i l i t y S o l u t i o n s M a r ke t L a n d s c a p e
5 . 1 H i s t o r i c a l a n d C u r r e n t M a r k e t Tr e n d s ( 2 0 1 8 - 2 0 2 3 )
5 . 2 M a r k e t Fo r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 G l o b a l H e a l t h c a r e I n t e r o p e r a b i l i t y S o l u t i o n s M a r ke t - B r e a k u p b y
Ty p e
6 . 1 S o f t w a r e S o l u t i o n s
6 . 1 . 1 O v e r v i e w
6 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t Tr e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3 M a r k e t S e g m e n t a t i o n
6 . 1 . 3 . 1 E H R I n t e r o p e r a b i l i t y S o l u t i o n s
6 . 1 . 3 .2 L a b S y s t em I n t e ro p e r a b i l i t y S o l u t i o n s
6 . 1 . 3 .3 I m a g in g Sy s t em I n t e ro p e r a b i l i t y S o l u t i o n s
6 . 1 . 3 .4 H ea l t h ca re I n f o rm a t i o n E xc h a n g e I n t e ro p e r a b i l i t y
So lu t i o n s
6 . 1 . 3 .5 E n t e r p r i s e I n t e ro pe r a b i l i t y S o lu t i o n s
6 . 1 . 3 .6 O t h e r s
6 . 1 . 4 M a r ke t Fo re ca s t ( 2 0 2 4 - 2 0 3 2 )
6 .2 Serv ices
6 . 2 . 1 O v e r v i e w
6 . 2 . 2 H i s t o r i c a l a n d C u r ren t M a r ke t Tre n d s ( 2 0 1 8 - 2 02 3 )
Table of 6 . 2 . 3 M a r ke t S e gm e n t a t i o n6 . 2 . 4 M a r ke t Fo re ca s t ( 2 0 2 4 - 2 0 3 2 )
6 .3 A t t rac t ive Inves tment Propos i t ion by Type
7 G loba l Hea l thcare In te roperab i l i ty So lu t ions Market -
Contents Breakup by Leve l7 .1 Foundat iona l
7 . 1 . 1 O v e r v i e w
7 . 1 . 2 H i s t o r i c a l a n d C u r ren t M a r ke t Tre n d s ( 2 0 1 8 - 2 02 3 )
7 . 1 . 3 M a r ke t S e gm e n t a t i o n
7 . 1 . 4 M a r ke t Fo re ca s t ( 2 0 2 4 - 2 0 3 2 )
7 .2 St ruc tu ra l
7 . 2 . 1 O v e r v i e w
7 . 2 . 2 H i s t o r i c a l a n d C u r ren t M a r ke t Tre n d s ( 2 0 1 8 - 2 02 3 )
7 . 2 . 3 M a r ke t S e gm e n t a t i o n
7 . 2 . 4 M a r ke t Fo re ca s t ( 2 0 2 4 - 2 0 3 2 )
7 .3 Semant ic
7 . 3 . 1 O v e r v i e w
7 . 3 . 2 H i s t o r i c a l a n d C u r ren t M a r ke t Tre n d s ( 2 0 1 8 - 2 02 3 )
7 . 3 . 3 M a r ke t S e gm e n t a t i o n
F o r m o r e i n f o r m a t i o n , v i s i t :
h t t p s : / / w w w. im a rcg ro u p . co m / h ea l t h ca re - i n t e ro p e r a b i l i t y - s o l u t i o
n s - m a r ke t / t o c
Disclaimer
© 2023 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: [email protected]
Comments